Peng W - Search Results

1

A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.

Gong J, Bao X, Wang T, Liu J, Peng W, Shi J, Wu F, Gu Y. Gong J, et al. Among authors: peng w. Oncoimmunology. 2022 Jan 25;11(1):2028962. doi: 10.1080/2162402X.2022.2028962. eCollection 2022. Oncoimmunology. 2022. PMID: 35096486 Free PMC article.

2

MRI characteristics of intraductal papilloma.

Wang W, Ding J, Yang W, Li Y, Zhou L, Zhang S, Zhu H, Mao J, Tang J, Gu Y, Peng W. Wang W, et al. Among authors: peng w. Acta Radiol. 2015 Mar;56(3):276-83. doi: 10.1177/0284185114526590. Epub 2014 Apr 2. Acta Radiol. 2015. PMID: 24696194

3

[Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].

Wu B, Huang X, Peng W, Gu Y, Yang T, Mao J, Ke G, Wu X. Wu B, et al. Among authors: peng w. Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):115-9. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 24796459 Chinese.

4

Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.

Tong T, Sun Y, Gollub MJ, Peng W, Cai S, Zhang Z, Gu Y. Tong T, et al. Among authors: peng w. J Magn Reson Imaging. 2015 Sep;42(3):673-80. doi: 10.1002/jmri.24835. Epub 2015 Feb 5. J Magn Reson Imaging. 2015. PMID: 25652254

5

Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma.

Wang W, Ding J, Zhu X, Li Y, Gu Y, Peng W. Wang W, et al. Among authors: peng w. PLoS One. 2015 Jul 10;10(7):e0132406. doi: 10.1371/journal.pone.0132406. eCollection 2015. PLoS One. 2015. PMID: 26161555 Free PMC article.

6

CT and MR imaging of thyroid carcinoma showing thymus-like differentiation (CASTLE): a report of ten cases.

Wu B, Sun T, Gu Y, Peng W, Wang Z, Bi R, Ji Q. Wu B, et al. Among authors: peng w. Br J Radiol. 2016;89(1060):20150726. doi: 10.1259/bjr.20150726. Br J Radiol. 2016. PMID: 26954328 Free PMC article.

7

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients.

You C, Peng W, Zhi W, He M, Liu G, Xie L, Jiang L, Hu X, Shen X, Gu Y. You C, et al. Among authors: peng w. Transl Oncol. 2017 Oct;10(5):786-792. doi: 10.1016/j.tranon.2017.07.005. Epub 2017 Aug 12. Transl Oncol. 2017. PMID: 28806712 Free PMC article.

8

Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer.

You C, Gu Y, Peng W, Li J, Shen X, Liu G, Peng W. You C, et al. Among authors: peng w. Acta Radiol. 2018 Jul;59(7):806-812. doi: 10.1177/0284185117738560. Epub 2017 Oct 24. Acta Radiol. 2018. PMID: 29065702

9

Diagnosis of breast cancer based on microcalcifications using grating-based phase contrast CT.

Li X, Gao H, Chen Z, Zhang L, Zhu X, Wang S, Peng W. Li X, et al. Among authors: peng w. Eur Radiol. 2018 Sep;28(9):3742-3750. doi: 10.1007/s00330-017-5158-4. Epub 2018 Jan 26. Eur Radiol. 2018. PMID: 29374322

10

The Assessment of Background Parenchymal Enhancement (BPE) in a High-Risk Population: What Causes BPE?

You C, Kaiser AK, Baltzer P, Krammer J, Gu Y, Peng W, Schönberg SO, Kaiser CG. You C, et al. Among authors: peng w. Transl Oncol. 2018 Apr;11(2):243-249. doi: 10.1016/j.tranon.2017.12.006. Epub 2018 Jan 28. Transl Oncol. 2018. PMID: 29413756 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,325 results

Search Page

Filters